NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NIH Office of Technology Transfer - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12381
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biological molecules, processes and pathways, medical technologies, and innovative applications to improve public health. It provides licensing and royalties that include licensing opportunities, royalties, startups, non-profit license, neglected diseases and rare diseases; initiating cooperative research and development agreements. NIH OTT transfers its medical knowledge from its laboratories to other organizations for the purpose of developing that knowledge into medical products. The center also offers training associated with technology transfer presentations and articles, intramural research training award fellowships, internship opportunities in federal technology transfer, and international training opportunities in federal technology transfer. NIH OTT is headquartered in Rockville, Maryland, the US.

NIH Office of Technology Transfer – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
KannaLife Sciences Enters Into Licensing Agreement With NIH 11
JSK Therapeutics Enters Into Licensing Agreement with NIH Office of Technology Transfer 12
KannaLife Sciences Enters Into Licensing Agreement With NIH-OTT 13
NIH Office of Technology Transfer – Key Competitors 14
NIH Office of Technology Transfer – Key Employees 15
NIH Office of Technology Transfer – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Key Facts 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KannaLife Sciences Enters Into Licensing Agreement With NIH 11
JSK Therapeutics Enters Into Licensing Agreement with NIH Office of Technology Transfer 12
KannaLife Sciences Enters Into Licensing Agreement With NIH-OTT 13
NIH Office of Technology Transfer, Key Competitors 14
NIH Office of Technology Transfer, Key Employees 15

List of Figures
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Autodesk Inc:企業のM&A・事業提携・投資動向
    Autodesk Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Autodesk Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Acxiom Corporation (ACXM):企業の財務・戦略的SWOT分析
    Acxiom Corporation (ACXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Isofol Medical AB (ISOFOL):製薬・医療:M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • National HealthCare Corp (NHC):企業の財務・戦略的SWOT分析
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance serv …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aaron’s Inc:企業の戦略・SWOT・財務分析
    Aaron's Inc - Strategy, SWOT and Corporate Finance Report Summary Aaron's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • New Zealand Post Limited:企業の戦略的SWOT分析
    New Zealand Post Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Eris Lifesciences Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a pharmaceutical company that manufactures and commercializes generics products. The company through its divisions provides wide range of products including Maxum, Decal, Eritel H, Eritel CH 80 LS, Glimisave Max Forte 1, Mac Rabonik Plus, Vomisave …
  • Shoppers Drug Mart Corporation:企業の戦略・SWOT・財務情報
    Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report Summary Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Glythera Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Glythera Ltd (Glythera) is a biotechnology company that focuses on the development of antibody drug conjugates (ADCs) and biotherapeutics for the treatment of cancer. The company develops antibody-based therapies for the treatment of cancer and broader based therapeutics. It uses its proprie …
  • Admedus Ltd (AHZ):製品パイプライン分析
    Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue r …
  • Doosan Infracore Co Ltd (042670):企業の財務・戦略的SWOT分析
    Doosan Infracore Co Ltd (042670) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • LHC Group, Inc.:企業のM&A・事業提携・投資動向
    LHC Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LHC Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Neuland Laboratories Ltd (NEULANDLAB):企業の財務・戦略的SWOT分析
    Summary Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company provides APIs in various therapeuti …
  • Challenger Ltd.:企業の戦略・SWOT・財務情報
    Challenger Ltd. - Strategy, SWOT and Corporate Finance Report Summary Challenger Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Asian American Medical Group Ltd (AJJ):企業の財務・戦略的SWOT分析
    Asian American Medical Group Ltd (AJJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Keihan Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Keihan Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Keihan Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • National Beverage Corp.:企業の戦略・SWOT・財務情報
    National Beverage Corp. - Strategy, SWOT and Corporate Finance Report Summary National Beverage Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mace Group Ltd:企業の戦略・SWOT・財務情報
    Mace Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Mace Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆